Effect Of Nintedanib On Pro-Fibrotic And Anti-Fibrotic Cytokine Release From Alveolar Macrophages In Interstitial Lung Diseases

被引：0
|
作者：
Bonella, F. [1 ]
Long, X. [1 ]
He, X. [1 ]
Theegarten, D. [2 ]
Wessendorf, T. E. [1 ]
Guzman, J. [3 ]
Costabel, U. [1 ]
机构：
[1] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany
[2] Univ Duisburg Essen, Uniklinikum Essen, Essen, Germany
[3] Ruhr Univ, Bochum, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3151
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases
    Liu, Feng
    Bayliss, George
    Zhuang, Shougang
    CLINICAL SCIENCE, 2019, 133 (12) : 1309 - 1320
  • [2] Anti-Fibrotic Effects Of Nintedanib On Lung Fibroblasts
    Rangarajan, S.
    Kurundkar, A.
    Kurundkar, D.
    Bernard, K.
    Sanders, Y.
    Ding, Q.
    Zhang, J.
    Zmijewski, J.
    Thannickal, V. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [3] Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
    Isshiki, Takuma
    Vierhout, Megan
    Naiel, Safaa
    Ali, Pareesa
    Yazdanshenas, Parichehr
    Kumaran, Vaishnavi
    Yang, Zi
    Dvorkin-Gheva, Anna
    Rullo, Anthony F.
    Kolb, Martin R. J.
    Ask, Kjetil
    BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [4] Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
    Lamb Y.N.
    Drugs, 2021, 81 (5) : 575 - 586
  • [5] Nintedanib Inhibits Pro-Fibrotic Mediators With Relevance In Connective Tissue Disease-Associated Interstitial Lung Diseases
    Wollin, L.
    Ostermann, A.
    Brauchle, V.
    Williams, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?
    Bellando-Randone, Silvia
    Della-Torre, Emanuel
    Balanescu, Andra
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (03) : 227 - 235
  • [7] Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis
    Sferra, Roberta
    Vetuschi, Antonella
    Pompili, Simona
    Gaudio, Eugenio
    Speca, Silvia
    Latella, Giovanni
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (01) : 58 - 65
  • [8] Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
    Yvette N. Lamb
    Drugs, 2021, 81 : 1133 - 1133
  • [9] Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
    Yvette N. Lamb
    Drugs, 2021, 81 (6) : 733 - 733
  • [10] Effect Of Nintedanib On Cytokine/chemokine Release From Alveolar Macrophages (ams) In Interstitial Lung Diseases (ilds): Preliminary Results
    Long, X.
    He, X.
    Theegarten, D.
    Wessendorf, T. E.
    Guzman, J.
    Costabel, U.
    Bonella, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345